Innovative Modular Neck Technology Enables Surgeons to Personalize Hip Replacement to a Patient's Anatomy
SAN FRANCISCO, CA - February 9, 2012 - Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal health, announced today at the American Academy of Orthopaedic Surgeons annual meeting in San Francisco that its Kinectiv® Technology for hip implants has now been used in more than 50,000 procedures worldwide. Kinectiv Technology enables surgeons to better match a patient's anatomy with modular neck options during hip replacement procedures.
"Every patient's anatomy is unique, requiring a personalized solution," said Jeff McCaulley, President, Zimmer Reconstructive. "Zimmer's Kinectiv Technology offers surgeons the greatest flexibility to personalize the fit of hip replacements through independent, intra-operative control of leg length, offset and version for a more accurate restoration of the patient's natural anatomy and motion."
Kinectiv Technology is offered in conjunction with the Zimmer® M/L Taper Hip Prosthesis, and more recently, with the new CLS® Brevius™ Hip Prosthesis.
The M/L Taper with Kinectiv Technology is a porous, cementless stem with a broad array of neck options to match a wide range of patient anatomies. The CLS Brevius Stem with Kinectiv Technology is shorter than conventional stems, providing greater bone conservation compared to other hip replacement systems.
For more information about Zimmer's Kinectiv Technology, visit the company at Booth 519 at the 2012 American Academy of Orthopaedic Surgeons annual meeting in San Francisco, or go to www.zimmer.com.
About Zimmer
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2011 sales were approximately $4.5 billion. The Company is supported by the efforts of more than 8,500 employees worldwide. For more information about Zimmer, visit www.zimmer.com.
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
Contacts:
Media
Garry R. Clark
574-372-4493
[email protected]
Investors
Robert J. Marshall Jr.
574-371-8042
[email protected]